Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) 'Tell Juliana'.
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Astodrimer (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms Tell Juliana
- 19 Jan 2010 Actual patient number (59) added as reported by ClinicalTrials.gov.
- 19 Jan 2010 Actual end date (November 2009) added as reported by ClinicalTrials.gov.
- 19 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.